Blue Water Vaccines, Inc. (BWV)

NASDAQ: BWV · Delayed Price · USD
4.65
-0.18 (-3.73%)
At close: May 18, 2022 4:00 PM
4.66
0.01 (0.22%)
Pre-market:May 19, 2022 4:27 AM EDT
Market Cap59.61M
Revenue (ttm)n/a
Net Income (ttm)-1.86M
Shares Out12.82M
EPS (ttm)-0.14
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,316,999
Open4.95
Previous Close4.83
Day's Range4.51 - 5.25
52-Week Range3.26 - 90.90
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About BWV

Blue Water Vaccines is a biotechnology company focused on the research and development of transformational vaccines to prevent infectious diseases worldwide. Our versatile vaccine platform has unique molecular properties that enables delivery of various antigens, which can be utilized to develop singular or multi-targeted vaccines. Our lead influenza (flu) vaccine program uses proprietary technology to identify specific epitopes, or proteins, with cross-reactive properties that enables the potential development of a universal flu vaccine. We ar...

IndustryBiotechnology
IPO DateFeb 18, 2022
CEOJoseph Hernandez
Employees2
Stock ExchangeNASDAQ
Ticker SymbolBWV
Full Company Profile

Financial Performance

Financial Statements

News

Blue Water Vaccines Reports First Quarter 2022 Financial Results and Recent Business Developments

CINCINNATI, May 13, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), today announced its financial results for the first quarter ended March 31, 2022 ...

5 days ago - GlobeNewsWire

Blue Water Vaccines Inc. to Present at H.C. Wainwright Global Investment Conference

CINCINNATI, May 12, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address signif...

6 days ago - GlobeNewsWire

5 Stocks Halted In Wednesday's Session: Here's Why

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore and bring...

Other symbols:CVNARDBXRKTU
1 week ago - Benzinga

Blue Water Vaccines Announces Expanded License Agreement with St. Jude Children's Research Hospital for Novel Bacteri...

CINCINNATI, May 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines, today announced...

1 week ago - GlobeNewsWire

Why Is Blue Water Vaccines (BWV) Stock Up Today?

Blue Water Vaccines turned heads as BWV stock shot up more than 90% with no apparent news. What's going on with BWV stock?

2 weeks ago - InvestorPlace

Blue Water Vaccines Presents New Data Supporting Universal Influenza Vaccine Candidate at the World Vaccine Congress ...

CINCINNATI, April 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines, today issued ...

3 weeks ago - GlobeNewsWire

Blue Water Vaccines Announces Closing of $8 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Proceeds To Fund Research and Development of BWV-101, BWV-102 and BWV-103 Proceeds To Fund Research and Development of BWV-101, BWV-102 and BWV-103

4 weeks ago - GlobeNewsWire

Blue Water Vaccines Announces $8 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Proceeds To Fund Research and Development of BWV-101, BWV 102 and BWV-103. Proceeds To Fund Research and Development of BWV-101, BWV 102 and BWV-103.

1 month ago - GlobeNewsWire

Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022

CINCINNATI, April 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address sign...

1 month ago - GlobeNewsWire

Blue Water Vaccines Announces Closing of Initial Public Offering

CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the closing of ...

2 months ago - GlobeNewsWire

Blue Water Vaccines Announces Pricing of approximate $20M Initial Public Offering

CINCINNATI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the pricing of...

3 months ago - GlobeNewsWire